Loading…
for educational and safety purposes
sci-wiki~$open stack lithium-orotate-mood
six items around a trace dose of lithium, and a straight account of what that dose can and cannot be doing
6 items; 5 structures drawn from pubchem, 1 drawn generically because pubchem has no record of the name.
Trace-dose lithium is one of the most interesting ideas in this whole catalogue and one of the least established. The interest is real: lithium at psychiatric doses has genuine neuroprotective pharmacology, brains with mild cognitive impairment measure lower in lithium, and a 2025 Nature paper showed that DEPLETING lithium in mice worsens amyloid deposition and repleting it prevents the loss.
The gap between that and a 1 to 5 milligram capsule is the whole story. The Nature work is a repletion experiment in animals put on a lithium-poor diet; correcting an induced deficiency is a different claim from supplementing a normally fed person. The human evidence at supplement doses is one small unreplicated trial at 300 micrograms and a body of drinking-water epidemiology whose dose-response is not even monotonic.
So the honest position is that this stack is cheap, is very unlikely to poison anyone at these doses, and has never been shown to do the thing it is taken for. That is a reasonable bet to make knowingly. It is not a reasonable bet to make because a label implied otherwise.
The items were chosen to cover lithium's supposed weak points rather than to combine with it pharmacologically, and most of them do not interact with it at all, which on a compound with this safety margin is a feature.
N-acetylcysteine, omega-3 and astaxanthin have no documented adverse interaction with lithium. The one direct co-administration study of NAC and lithium is a rat model where NAC PROTECTED the kidney against lithium injury, which is encouraging and is also a rat.
⚠️ Cerebrolysin is the exception and it points the wrong way. The only published pharmacokinetic observation on the pair reports lithium accumulating in brain tissue during Cerebrolysin treatment. On any other compound that would be a curiosity; on lithium it is a reason to hold.
At these doses most people report nothing at all, which is the honest expectation and is also why the category is so hard to evaluate. Reports of a calmer baseline are common and are exactly what an inactive dose plus an expectation produces.
⚠️ LITHIUM HAS THE NARROWEST SAFETY MARGIN OF ANYTHING ON THIS SITE. The FDA label for lithium carbonate carries a boxed warning stating that lithium toxicity is closely related to serum concentrations and can occur at doses close to therapeutic ones. The treatment range is 0.8 to 1.2 mEq/L and toxicity begins at 1.5. That is the entire margin. Supplement doses sit far below that range, and that cuts both ways. One to five milligrams of elemental lithium is roughly 20 to 200 times less than a psychiatric dose; a woman taking an over-the-counter lithium orotate product measured below 0.05 mmol/L, about a twentieth of the low end of the treatment range. At that level the classical toxicities are very unlikely. At that level the classical benefits have also never been demonstrated. No case of harm from chronic supplement-dose lithium orotate has been published, and that is an absence of study rather than a safety demonstration. ⚠️ THE OROTATE SUPERIORITY CLAIM IS REFUTED, NOT MERELY UNPROVEN, and it underpins the entire product category. It traces to a single 1978 rat injection study. The following year, in the same journal, Mogens Schou, the clinician who established lithium therapy, repeated the experiment while also measuring kidney function and found the higher brain lithium was explained by REDUCED RENAL CLEARANCE FROM KIDNEY INJURY; his conclusion was that it seems inadvisable to use lithium orotate for the treatment of patients. There has never been a randomised controlled trial of lithium orotate in humans, at any dose, for any indication. WHAT LITHIUM DOES AT TREATMENT DOSES, so a reader knows what is being scaled down from. Clinical hypothyroidism odds rise roughly sixfold against placebo; prevalence reaches 35 percent in older patients and 41 percent in older women, and ultrasound found goitre in 53 of 96 treated patients against 19 of 96 controls, with palpation missing more than half of it. Urinary concentrating ability falls about 15 percent, and stage 3 kidney disease risk rises about 35 percent, though end-stage disease risk does not. Blood calcium and parathyroid hormone rise consistently enough that calcium is worth checking at baseline. None of these has been looked for at supplement doses. ⚠️ DRUGS THAT RAISE LITHIUM DANGEROUSLY. In a study of 10,615 older lithium users, starting an ACE inhibitor raised hospitalisation for lithium toxicity roughly sevenfold and a loop diuretic roughly fivefold, within the first month. NSAIDs including ibuprofen reduce lithium clearance with wide variation between people; COX-2 inhibitors are not an exception and have doubled serum lithium in case reports. Angiotensin receptor blockers belong on the same list. ⚠️ DEHYDRATION AND SALT RESTRICTION ARE THE MOST COMMON REAL TRIGGER AND INVOLVE NO DRUG AT ALL. Lithium behaves like sodium in the kidney, so a low-salt diet, a fasting protocol, a sauna habit, a stomach bug or a hot week can concentrate it. In one published case a man stable for twenty years developed diarrhoea, kept taking everything, and arrived in hospital at 2.7 mmol/L with acute kidney failure. EARLY SIGNS, from the label: fine tremor, lightheadedness, loss of coordination and weakness, progressing to giddiness, apathy, drowsiness, muscle twitching, ataxia, blurred vision, tinnitus and slurred speech. Severity tracks blood levels poorly and recovery can be slow; in one series of 22 neurotoxicity admissions the median hospital stay was 13 days. ⚠️ PREGNANCY. First-trimester lithium is associated with increased cardiac malformations, risk ratio about 1.65, and with right ventricular outflow tract obstruction defects specifically, 0.60 percent against 0.18 percent. The risk is dose-dependent and concentrated above 900 milligrams a day of carbonate. The old figure of a 400-fold increase in Ebstein anomaly came from an uncontrolled registry and is not supported; the current estimate is on the order of one additional cardiac case per 100 live births. This is a clinician's decision. Lithium also appears on standard lists of agents that can contribute to serotonin toxicity alongside SSRIs, SNRIs, MAO inhibitors and triptans, with the risk window when a serotonergic drug is added or a dose changes; that evidence is case-level rather than quantified. ⚠️ NO AUTHORITY HAS ISSUED A MONITORING EXEMPTION FOR LOW-DOSE LITHIUM. Researchers proposing trace-dose lithium orotate are proposing a clinical trial that has not been run. Anyone with kidney disease, thyroid disease, heart disease, or taking any of the drug classes above should speak to a clinician first, and should not treat a supplement label as a reason to skip that conversation.
nothing flaggedcurated roster
every pair here reads as compatible on the mechanisms the site holds. that is the absence of a known conflict, not a clearance.
4 of 6 in one basketAmazon
Fish Oil has no outlet here at all.
4 of 6 priced
2 of these carry no listed price, so there is no honest total to print; the lines above are what can actually be costed.
no overlap found
no two of these share a primary class or a listed receptor. every item is pulling a different lever.
interested in protocols? join the discord; that is where dosing, timing and the practical side get discussed.
the sci-wiki publishes this as a description of what these compounds do together, not as a recommendation to take them. Nothing here is medical advice.